Literature DB >> 27052251

Transcriptional modules related to hepatocellular carcinoma survival: coexpression network analysis.

Xinsen Xu1, Yanyan Zhou1, Runchen Miao1, Wei Chen1, Kai Qu1, Qing Pang1, Chang Liu2.   

Abstract

We performed weighted gene coexpression network analysis (WGCNA) to gain insights into the molecular aspects of hepatocellular carcinoma (HCC). Raw microarray datasets (including 488 samples) were downloaded from the Gene Expression Omnibus (GEO) website. Data were normalized using the RMA algorithm. We utilized the WGCNA to identify the coexpressed genes (modules) after non-specific filtering. Correlation and survival analyses were conducted using the modules, and gene ontology (GO) enrichment was applied to explore the possible mechanisms. Eight distinct modules were identified by the WGCNA. Pink and red modules were associated with liver function, whereas turquoise and black modules were inversely correlated with tumor staging. Poor outcomes were found in the low expression group in the turquoise module and in the high expression group in the red module. In addition, GO enrichment analysis suggested that inflammation, immune, virus-related, and interferon-mediated pathways were enriched in the turquoise module. Several potential biomarkers, such as cyclin-dependent kinase 1 (CDK1), topoisomerase 2α (TOP2A), and serpin peptidase inhibitor clade C (antithrombin) member 1 (SERPINC1), were also identified. In conclusion, gene signatures identified from the genome-based assays could contribute to HCC stratification. WGCNA was able to identify significant groups of genes associated with cancer prognosis.

Entities:  

Keywords:  coexpression; hepatocellular carcinoma; microarray; module; prognosis

Mesh:

Year:  2016        PMID: 27052251     DOI: 10.1007/s11684-016-0440-4

Source DB:  PubMed          Journal:  Front Med        ISSN: 2095-0217            Impact factor:   4.592


  31 in total

1.  Identification of molecular markers for the oncogenic differentiation of hepatocellular carcinoma.

Authors:  Gyung Ran Yu; Seong Hun Kim; Seon Hwa Park; Xiang Dan Cui; Dong Yuan Xu; Hee Chul Yu; Baik Hwan Cho; Young Il Yeom; Sang Soo Kim; Sang Bae Kim; In Sun Chu; Dae Ghon Kim
Journal:  Exp Mol Med       Date:  2007-10-31       Impact factor: 8.718

Review 2.  The history and future of targeting cyclin-dependent kinases in cancer therapy.

Authors:  Uzma Asghar; Agnieszka K Witkiewicz; Nicholas C Turner; Erik S Knudsen
Journal:  Nat Rev Drug Discov       Date:  2015-02       Impact factor: 84.694

3.  Gene modules and response to neoadjuvant chemotherapy in breast cancer subtypes: a pooled analysis.

Authors:  Michail Ignatiadis; Sandeep K Singhal; Christine Desmedt; Benjamin Haibe-Kains; Carmen Criscitiello; Fabrice Andre; Sherene Loi; Martine Piccart; Stefan Michiels; Christos Sotiriou
Journal:  J Clin Oncol       Date:  2012-04-16       Impact factor: 44.544

4.  Coexpression network analysis identifies transcriptional modules related to proastrocytic differentiation and sprouty signaling in glioma.

Authors:  Alexander E Ivliev; Peter A C 't Hoen; Marina G Sergeeva
Journal:  Cancer Res       Date:  2010-12-15       Impact factor: 12.701

5.  A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients.

Authors:  Stephanie Roessler; Hu-Liang Jia; Anuradha Budhu; Marshonna Forgues; Qing-Hai Ye; Ju-Seog Lee; Snorri S Thorgeirsson; Zhongtang Sun; Zhao-You Tang; Lun-Xiu Qin; Xin Wei Wang
Journal:  Cancer Res       Date:  2010-12-15       Impact factor: 12.701

6.  Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target.

Authors:  S Horvath; B Zhang; M Carlson; K V Lu; S Zhu; R M Felciano; M F Laurance; W Zhao; S Qi; Z Chen; Y Lee; A C Scheck; L M Liau; H Wu; D H Geschwind; P G Febbo; H I Kornblum; T F Cloughesy; S F Nelson; P S Mischel
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-07       Impact factor: 11.205

Review 7.  Hepatocellular carcinoma: novel molecular approaches for diagnosis, prognosis, and therapy.

Authors:  Augusto Villanueva; Beatriz Minguez; Alejandro Forner; Maria Reig; Josep M Llovet
Journal:  Annu Rev Med       Date:  2010       Impact factor: 13.739

8.  Gene expression-based recurrence prediction of hepatitis B virus-related human hepatocellular carcinoma.

Authors:  Hyun Goo Woo; Eun Sung Park; Jae Hee Cheon; Ju Han Kim; Ju-Seog Lee; Bum Joon Park; Won Kim; Su Cheol Park; Young Jin Chung; Byeong Gwan Kim; Jung-Hwan Yoon; Hyo-Suk Lee; Chung Yong Kim; Nam-Joon Yi; Kyung-Suk Suh; Kuhn Uk Lee; In-Sun Chu; Tania Roskams; Snorri S Thorgeirsson; Yoon Jun Kim
Journal:  Clin Cancer Res       Date:  2008-04-01       Impact factor: 12.531

Review 9.  Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma.

Authors:  Mary Maluccio; Anne Covey
Journal:  CA Cancer J Clin       Date:  2012-10-15       Impact factor: 508.702

10.  The FANC pathway is activated by adenovirus infection and promotes viral replication-dependent recombination.

Authors:  Gioia Cherubini; Valeria Naim; Paola Caruso; Romina Burla; Massimo Bogliolo; Enrico Cundari; Karim Benihoud; Isabella Saggio; Filippo Rosselli
Journal:  Nucleic Acids Res       Date:  2011-03-17       Impact factor: 16.971

View more
  11 in total

Review 1.  A Path to Implement Precision Child Health Cardiovascular Medicine.

Authors:  Marlin Touma; Brian Reemtsen; Nancy Halnon; Juan Alejos; J Paul Finn; Stanley F Nelson; Yibin Wang
Journal:  Front Cardiovasc Med       Date:  2017-06-01

2.  Identification of prognostic risk factors for pancreatic cancer using bioinformatics analysis.

Authors:  Dandan Jin; Yujie Jiao; Jie Ji; Wei Jiang; Wenkai Ni; Yingcheng Wu; Runzhou Ni; Cuihua Lu; Lishuai Qu; Hongbing Ni; Jinxia Liu; Weisong Xu; MingBing Xiao
Journal:  PeerJ       Date:  2020-06-15       Impact factor: 2.984

3.  CCNB2, TOP2A, and ASPM Reflect the Prognosis of Hepatocellular Carcinoma, as Determined by Weighted Gene Coexpression Network Analysis.

Authors:  Yuping Zeng; He He; Yu Zhang; Xia Wang; Lidan Yang; Zhenmei An
Journal:  Biomed Res Int       Date:  2020-06-23       Impact factor: 3.411

4.  Network analysis of drug effect on triglyceride-associated DNA methylation.

Authors:  Elise Lim; Hanfei Xu; Peitao Wu; Daniel Posner; Jiayi Wu; Gina M Peloso; Achilleas N Pitsillides; Anita L DeStefano; L Adrienne Cupples; Ching-Ti Liu
Journal:  BMC Proc       Date:  2018-09-17

5.  Transcriptome Analysis Revealed a Highly Connected Gene Module Associated With Cirrhosis to Hepatocellular Carcinoma Development.

Authors:  Shan Shan; Wei Chen; Ji-Dong Jia
Journal:  Front Genet       Date:  2019-04-02       Impact factor: 4.599

6.  TUG1 Promoted Tumor Progression by Sponging miR-335-5p and Regulating CXCR4-Mediated Infiltration of Pro-Tumor Immunocytes in CTNNB1-Mutated Hepatoblastoma.

Authors:  Fujing Xie; Lianhai Zhang; Qing Yao; Liyu Shan; Jike Liu; Nanhai Dong; Jun Liang
Journal:  Onco Targets Ther       Date:  2020-04-14       Impact factor: 4.147

7.  Identification of two novel biomarkers of rectal carcinoma progression and prognosis via co-expression network analysis.

Authors:  Min Sun; Taojiao Sun; Zhongshi He; Bin Xiong
Journal:  Oncotarget       Date:  2017-06-27

8.  Identification of long non-coding RNA signature for paclitaxel-resistant patients with advanced ovarian cancer.

Authors:  Luqing Wang; Yanjun Hu; Xiaohong Xiang; Kai Qu; Yue Teng
Journal:  Oncotarget       Date:  2017-08-02

9.  Weighted Gene Co-expression Network Analysis of Endometriosis and Identification of Functional Modules Associated With Its Main Hallmarks.

Authors:  Mohammad Reza Bakhtiarizadeh; Batool Hosseinpour; Maryam Shahhoseini; Arthur Korte; Peyman Gifani
Journal:  Front Genet       Date:  2018-10-12       Impact factor: 4.599

10.  In silico identification of EP400 and TIA1 as critical transcription factors involved in human hepatocellular carcinoma relapse.

Authors:  Weiguo Hong; Yan Hu; Zhenping Fan; Rong Gao; Ruichuang Yang; Jingfeng Bi; Jun Hou
Journal:  Oncol Lett       Date:  2019-12-02       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.